Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mark A de Belder"'
Autor:
Mandeep S. Sidhu, Karen P. Alexander, Zhen Huang, Sean M. O'Brien, Bernard R. Chaitman, Gregg W. Stone, Jonathan D. Newman, William E. Boden, Aldo P. Maggioni, Philippe Gabriel Steg, Thomas B. Ferguson, Marcin Demkow, Jesus Peteiro, Gurpreet S. Wander, Denis C. Phaneuf, Mark A. De Belder, Rolf Doerr, Erick Alexanderson-Rosas, Carisi A. Polanczyk, Peter A. Henriksen, Dwayne S.G. Conway, Vicente Miro, Tali Sharir, Renato D. Lopes, James K. Min, Daniel S. Berman, Frank W. Rockhold, Stephen Balter, David Borrego, Yves D. Rosenberg, Sripal Bangalore, Harmony R. Reynolds, Judith S. Hochman, David J. Maron
Publikováno v:
Am Heart J
The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches trial demonstrated no overall difference in the composite primary endpoint and the secondary endpoints of cardiovascular (CV) death/myocardial infarction
Autor:
Samuel Copt, Tim Kinnaird, Richard Anderson, Nick Curzen, Colm G. Hanratty, James C. Spratt, Adrian P. Banning, Peter Ludman, Mark A. de Belder, Simon J Walsh, Mamas A. Mamas, Sean Gallagher
Publikováno v:
American heart journal. 222
Complex high-risk and indicated revascularization using percutaneous coronary intervention (CHIP-PCI) is an emerging concept that is poorly studied.To define temporal changes in CHIP-PCI volumes, and the relationship between operator CHIP-PCI volume
Autor:
A. A. Harcombe, Kunadian Vijayalakshmi, James A Hall, Mark A. de Belder, Nicholas J. Linker, Jerry Murphy, Michael J. Stewart, Andrew G.C. Sutton, Babu Kunadian, Robert A. Wright, Janine C. Gray, Adrian Davies, A Shyam-Sundar, E D Grech, Andrew R. Thornley, Roger H. Smith
Publikováno v:
American Heart Journal. 153:763-771
Early (30 days) and midterm (6 months) clinical outcomes in trials comparing rescue angioplasty (rescue percutaneous coronary intervention [rPCI]) with conservative treatment of failed fibrinolysis complicating ST-segment elevation myocardial infarct
Publikováno v:
American Heart Journal. 128:620-623
Copyright @ 1994 by Mosby-Year Book, Inc. 0002-8703/94/$3.00 + 0 4/4/57331 A small number of patients with ventricular tachycardia (VT) have no obvious identifiable cardiac or systemic abnormality associated with the arrhythmia.l The majority of such
Publikováno v:
American Heart Journal. 124:1545-1550
The detection of shunts at the atrial level is important, and a reliable means of diagnosis is required. Precordial contrast echocardiography is usually performed to detect such shunts. To investigate the advantages of transesophageal echocardiograph
Autor:
Nicholas J. Linker, Andrew G.C. Sutton, James A Hall, P G Campbell, Michael J. Stewart, Robert A. Wright, A. A. Harcombe, Kunadian Vijayalakshmi, Mark A. de Belder, Victoria Whittaker, Adrian Davies
Publikováno v:
American heart journal. 151(4)
Antiarrhythmic agents enhance maintenance of sinus rhythm (SR) after direct current cardioversion (DCC) for atrial fibrillation but there are few comparative trials. Background The aims of the study were (1) to establish whether patients successfully
Autor:
Mamas A. Mamas, Peter Ludman, James Nolan, Helen Routledge, Mark A. de Belder, Douglas G. Fraser, Iain Buchan, Ludwig Neyses, Simon G. Anderson, Karim Ratib
Publikováno v:
American Heart Journal. 167:900-908.e1
Cardiogenic shock (CS) remains the leading cause of mortality in patients hospitalized with acute myocardial infarction (AMI). The transradial access site (TRA) has become increasingly adopted as a default access site for percutaneous coronary interv
Autor:
Paul Finn, Mark A. de Belder, Adrian Davies, Ever D. Grech, Andrew G.C. Sutton, Michael J. Stewart, James A. Hall
Publikováno v:
American heart journal. 141(4)
Although modern contrast agents have tolerability superior to older agents, significant differences remain between the agents currently in use.To investigate the incidence of early (24 hours) and late (24 hours to 7 days) reactions to 3 contrast agen